SkyQuest Technology Group recently introduced Cardiovascular Devices Market study with in-depth overview, describing about the Product/Industry Scope and elaborates market outlook and status (2025-2032). The market Study is segmented by key regions which is accelerating the marketization. The Cardiovascular Devices Market has witnessed Excellent growth over the past decade and is expected to maintain its upward trajectory.
Cardiovascular Devices Market size was valued at USD 61.52 billion in 2023 and is poised to grow from USD 66.20 billion in 2024 to USD 118.95 billion by 2032, growing at a CAGR of 7.6% during the forecast period (2025-2032).
The growth of the global cardiovascular devices market is driven by the high prevalence of chronic cardiovascular diseases. For example, according to a Harvard study, T.H. Chan School of Public Health (HSPH), located in the Indian state of Maharashtra, has seen a 43.0% increase in the number of cardiac arrests due to the fall in coronary stent prices. Moreover, the sharp decline in the prices of essential cardiac drugs such as coronary artery bypass therapy is fueling the expansion of this market, especially in emerging markets like India.
Get a Free Sample PDF of the Report – https://www.skyquestt.com/sample-request/cardiovascular-devices-market
The 2025 global Cardiovascular Devices Market report provides a comprehensive analysis of key industry players, market trends, pricing structures, and competitive dynamics, offering insights into the market landscape from 2025 to 2032. As a rapidly evolving sector, the Cardiovascular Devices Market drives economic growth, innovation, and technological advancements through the development, production, and distribution of products and services. This report highlights the market’s growth potential and its impact on global industries, providing valuable insights for stakeholders, investors, and policymakers.
Detailed Segmentation and Classification of the report (Market Size and Forecast – 2032, Y-o-Y growth rate, and CAGR):
The Cardiovascular Devices Market can be segmented based on several factors, including product type, application, end-user, and distribution channel.
Cardiovascular Devices Market is segmented by product, application, end user and region.
Based on product, the market is segmented into Diagnostic & Monitoring Devices (ECG, Implantable Cardiac Monitors, Holter Monitors, Mobile Cardiac Telemetry, MRI, Cardiovascular Ultrasound (2D, 3D/4D, Doppler), Cardiac Diagnostic Catheters, PET Scanner), Surgical Devices (Cardiac Resynchronization Therapy (CRT) (CRT-Defibrillator, CRT-Pacemaker), Implantable Cardioverter Defibrillators (ICDs) (Single Chamber ICDs, Dual Chamber ICDs), Pacemakers (Conventional Pacemakers, Leadless Pacemakers), Coronary Stents, Catheters, Guidewires, Cannula, Valves, Occlusion Devices).
Based on application, the market is segmented into Coronary Artery Disease (CAD), Cardiac Arrhythmia, Heart Failure and Others.
Based on end user, the market is segmented into Hospitals, Specialty Clinics and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.
Cardiovascular Devices Market – Regional Analysis:
As per cardiovascular devices market outlook, North America dominated the market and accounted for the largest cardiovascular devices market share at 47.7% in 2024, driven by rising atrial fibrillation (AFib) & cardiovascular disease (CVD), supportive government policies and the technological advancements. This atrial fibrillation (AF) is very common, which is considered a risk factor for it has a lifetime incidence of approximately 1 in 3 to 5 people over the age of 45.
The Asia-Pacific region in the cardiovascular devices market is expected to grow rapidly, with a projected CAGR of 8.9% between 2024 to 2031. The increasing geriatric population in Asia Pacific contributes to the growth of the market. In 2024, The Asian Development Bank (ADB) projected that by 2050 there will be 1.2 billion People aged 60 and over and they live in developing Asia-Pacific, representing about a quarter of the total population.
Top Market Players in Cardiovascular Devices Market are:
Abbott Laboratories
Boston Scientific Corporation
Medtronic, Inc.
Johnson & Johnson
Terumo Corporation
Edwards Lifesciences Corporation
Biotronik SE & Co. KG
LivaNova PLC
Getinge AB
Baxter International Inc. (Hill-Rom Holdings, Inc.)
Koninklijke Philips N.V.
Siemens Healthineers AG
GE Healthcare
Toshiba Corporation
Fujifilm Holdings Corporation
Hitachi, Ltd.
Nihon Kohden Corporation
Collateral Medical Pvt. Ltd.
Schiller AG
B. Braun Melsungen AG
For a customized report, contact us to request personalization – https://www.skyquestt.com/speak-with-analyst/cardiovascular-devices-market
Cardiovascular Devices Market Recent Developments:
October 2022: Medtronic plc received United States FDA approval to expand cardiac lead labeling by stimulating the heart’s natural electrical current, allowing patients to receive the treatment.
March 2024: Stryker introduced the LIFEPAK CR2 AED and evacuation chair for cardiac monitoring. The LIFEPAK CR2 helps rescuers quickly deliver CPR and shock in the event of sudden cardiac arrest, with the quick deployment of QUIK-STEP electrodes and a Shock Advisory System for ECG monitoring.
October 2022: Biosense Webster, Inc., a division of Johnson & Johnson MedTech, launched the HELIOSTAR balloon ablation catheter in Europe. The HELIOSTAR balloon ablation catheter is indicated for use in catheter-based cardiac electrophysiological mapping (and stimulation and recording) of the atria, and when used with a compatible multichannel RF generator, for use in the heart.
Take Action Now: Secure Your Cardiovascular Devices Market Today – https://www.skyquestt.com/buy-now/cardiovascular-devices-market
Forward-Looking Insights
The Cardiovascular Devices Market is set to experience sustained growth, fueled by technological advancements, broader global market access, and rising industry demand. With the industry addressing emerging challenges and capitalizing on new opportunities, it is expected to drive innovation and play a pivotal role in advancing global health and economic progress.
About Company:
SkyQuest is an IP focused Research and Investment Bank and Accelerator of Technology and assets. We provide access to technologies, markets and finance across sectors viz. Life Sciences, CleanTech, AgriTech, NanoTech and Information & Communication Technology.
We work closely with innovators, inventors, innovation seekers, entrepreneurs, companies and investors alike in leveraging external sources of R&D. Moreover, we help them in optimizing the economic potential of their intellectual assets. Our experiences with innovation management and commercialization have expanded our reach across North America, Europe, ASEAN and Asia Pacific.
Contact Details:
SkyQuest Technology Group
USA (+1) 351-333-4748
Email: [email protected]
